Graduate Program Will be Offered in Partnership With Albert Einstein College of Medicine and Montefiore Health System
Yeshiva University will introduce a new master of science degree program in speech-language pathology (SLP) in fall 2015. Students enrolled in the new program will have the opportunity to learn from the experienced clinicians and faculty of the Montefiore Health System and the Albert Einstein College of Medicine, and will have access to resources at both institutions. The program is approved by the State of New York Department of Higher Education and is seeking Accreditation Candidacy with the Council on Academic Accreditation (CAA) of the American Speech, Language and Hearing Association (ASHA). The official opening date is pending CAA accreditation.
Dr. Linda Carroll will direct the new program in speech-language pathology.
The five-semester graduate program is designed to prepare students to become speech-language pathologists who are capable of working in hospitals, rehabilitative centers, university or college clinics, specialized clinical settings or private practice. The program was developed by Linda Carroll, Ph.D., speech pathologist, Department of Otolaryngology, Montefiore Medical Center, who will serve as director. Dr. Carroll is also an experienced voice therapist and was recently named a Fellow of ASHA.
“This master’s program is not only responsive to the needs of YU students who are interested in the health sciences, but also critical to the community as it seeks to hire accomplished speech-language therapists,” said Dr. Selma Botman, provost and vice president for academic affairs at YU. “We are fortunate to have Dr. Carroll, a nationally recognized expert in the field, lead this initiative.” Read the rest of this entry…
YU Undergraduates Participate in Cutting-Edge Summer Scientific Research Program at Einstein
After a challenging year of academic study as a biology major concentrating in molecular and cellular biology at Yeshiva University’s Stern College for Women, Liat Weinstock, of Cedarhurst, New York, isn’t spending her well-deserved summer break at camp or on a beach. Instead, she’s working with Dr. Rebecca Madan’s pediatric infectious diseases team on a research study examining the effects of certain drug-resistant bacteria on transplant patients after their operations.
From left: Natan Tracer, Liat Weinstock, Shira Kaye, Hadassa Holzapfel, Adi Cohen, Esther Kazlow, Jacqueline Benayoun, Bracha Robinson and Tamar Ariella Lunzer
“If we’re able to uncover some new information about how our immune system works and recovers, we can then change how we practice medicine to better treat patients with diseases,” said Weinstock. “My responsibilities here have been especially interesting to me because they almost feel like detective work—I find clues in patients’ charts that lead me to the correct labs and test results to determine whether a patient will fit our study or not. Putting together all the clues and coming up with an answer is an exciting ‘Eureka!’ moment.”
Montefiore Health System and Yeshiva University Come to Historic Agreement for Future of Albert Einstein College of Medicine; Agreement Enhances and Strengthens Shared Missions in a More Sustainable Model
Montefiore Health System and Yeshiva University have come to an historic agreement to build upon a longstanding, 50-year relationship that has trained generations of physicians and medical researchers. A new entity will be jointly formed by Montefiore and Yeshiva, with Montefiore assuming greater responsibility for the day-to-day operations and financial management of Albert Einstein College of Medicine and with Yeshiva remaining the degree-granting institution with a key role in the educational aspects of the entity. Montefiore has agreed to assume significant governance and financial responsibility for the new Einstein entity.
“This agreement marks an important milestone for the future of each of our institutions as well as for healthcare as a whole,” said Steven M. Safyer, M.D., president and CEO, Montefiore. “We look forward to further strengthening Einstein as a major research institution that spans the scope from bench science to healthcare delivery transformation.”
The agreement enhances and strengthens the organizations’ shared missions of research, teaching, patient care and community service and will ensure Einstein remains a leading medical school.
“We are undertaking this historic process of transforming our relationship with Montefiore and Einstein to match the extraordinary opportunities and challenges in the healthcare environment of the 21st century,” said Richard M. Joel, president, Yeshiva University. Read the rest of this entry…
Project TEACH Volunteers Create Interactive Science Modules for Children in Hospitals
Explosive milk fireworks, bridges built from gumdrops and suspenseful egg drop competitions: they may sound like wacky science experiments gone awry, but these are all fun and educational activities for children that may soon be coming to a hospital near you.
Yosefa Schoor, left, and Laura Taieb, right, work with children in Columbia University’s Morgan Stanley Children’s Hospital to create a volcano.
Welcome to Project TEACH – Together Educating All Children in Hospitals, a joint initiative from Yeshiva University undergraduates and students at the Albert Einstein College of Medicine in which volunteers design, develop and implement a series of science and humanities modules for pediatric patients. The program currently operates in eight hospitals in New York, with over 270 volunteers running informational and recreational activities for children and their families. Its largest event took place this spring, when more than 30 YU students constructed volcanoes with patients at Columbia University’s Morgan Stanley Children’s Hospital.
Veterans’ Head Injury Examined by Researchers at Albert Einstein College of Medicine
Roadside bombs and other blasts have made head injury the “signature wound” of the Iraq and Afghanistan conflicts. Most combat veterans recover from mild traumatic brain injury, also known as concussion, but a small minority experience significant and long-term side effects.
Now, researchers at Albert Einstein College of Medicine of Yeshiva University, in cooperation with Resurrecting Lives Foundation, are investigating the effect of repeated combat-related blast exposures on the brains of veterans with the goal of improving diagnostics and treatment. Read the rest of this entry…
Researchers to Study Diabetes Self-Management and Behavioral Interventions
More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their health care provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels. Consistent adherence to oral medications and injectable insulin, both used to keep blood glucose levels in check, is particularly challenging among young patients and ethnic minorities. Consequences are significant: lack of adherence can lead to or exacerbate eye disease, kidney disease and nerve damage.
David Brooks to Keynote December 8 Convocation; Jack Belz, Dr. Susan Horwitz, Harvey Kaylie and William Zabel to be Honored
David Brooks, acclaimed journalist, author and New York Times columnist will be the keynote speaker and receive an honorary doctorate at Yeshiva University’s 89th Annual Hanukkah Convocation and Dinner on Sunday, December 8, at The Waldorf Astoria in New York City.
New York Times columnist David Brooks will keynote YU’s Hanukkah convocation.
In addition to Brooks, YU President Richard M. Joel will confer honorary degrees upon Jack A. Belz of Memphis, TN, chairman and CEO of Belz Enterprises and a Benefactor and Trustee of Yeshiva University; Harvey Kaylie of Great Neck, NY, founder, president and CEO of Mini-Circuits International and a YU Benefactor; and William Zabel of Manhattan, founding partner of Schulte, Roth & Zabel and head of the Individual Client Services Group. President Joel will also present the Presidential Medallion to Dr. Susan B. Horwitz of Larchmont, NY, Rose Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Yeshiva University’s Albert Einstein College of Medicine. Read the rest of this entry…
The conference will explore the ways in which Israeli medical institutions utilize Jewish law to form national policy as well as several important ethical and halachic questions that emerge from practicing medicine in Israel. Read the rest of this entry…
Einstein-Montefiore Researchers Secure $16 Million NIH Grant to Study HIV/AIDS in Women
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $16 million grant from the National Institutes of Health (NIH) to investigate the impact of HIV and AIDS on women. The funds allow Montefiore and Einstein to continue as a scientific and clinical site for the Women’s Interagency HIV Study (WIHS), a multi-center, prospective, observational study of women who are either HIV-positive or at risk for HIV infection. The study is now entering its 21st year. Read the rest of this entry…
Crohn’s Disease and Ulcerative Colitis More Common Among Ashkenazi Jews
Individuals seeking to learn about Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease or IBD) can self-educate at GeneSights, the free online education resource presented by the Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine. IBD affects more than 1.4 million Americans and its prevalence is significantly higher in individuals of Ashkenazi Jewish descent as compared to the general population.
GeneSights consists of individual “lessons” with topics selected based on their current relevance to the Jewish community, including specific diseases and medical conditions, genetic technologies and bioethical issues. Read the rest of this entry…